Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $957,440 |
| Sells | 79 | $51,735,123 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 13 Mar 2025 20:15 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 12 Mar 2025 | Sale | 79,264 | 8.3511 | 661,942 | D |
| 06 Dec 2024 17:51 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 04 Dec 2024 | Sale | 67,608 | 5.0018 | 338,162 | D |
| 06 Dec 2024 17:51 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 05 Dec 2024 | Sale | 640,264 | 5.0061 | 3,205,226 | D |
| 06 Dec 2024 17:51 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 06 Dec 2024 | Sale | 162,800 | 5.0086 | 815,400 | D |
| 06 Dec 2024 17:50 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Dec 2024 | Sale | 58,184 | 5.0013 | 290,996 | D |
| 06 Dec 2024 17:50 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 05 Dec 2024 | Sale | 640,048 | 5.0061 | 3,204,144 | D |
| 06 Dec 2024 17:50 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 06 Dec 2024 | Sale | 183,728 | 5.0091 | 920,312 | D |
| 02 Dec 2024 19:20 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 27 Nov 2024 | Sale | 12,936 | 5 | 64,680 | D |
| 02 Dec 2024 19:20 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 29 Nov 2024 | Sale | 98,704 | 5.0063 | 494,142 | D |
| 02 Dec 2024 19:20 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 02 Dec 2024 | Sale | 1,600 | 5 | 8,000 | D |
| 02 Dec 2024 19:19 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 27 Nov 2024 | Sale | 23,240 | 5 | 116,200 | D |
| 02 Dec 2024 19:19 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 29 Nov 2024 | Sale | 98,888 | 5.006 | 495,033 | D |
| 02 Dec 2024 19:19 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 02 Dec 2024 | Sale | 3,200 | 5 | 16,000 | D |
| 26 Nov 2024 18:36 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 25 Nov 2024 | Sale | 1,600 | 5 | 8,000 | D |
| 26 Nov 2024 18:36 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 26 Nov 2024 | Sale | 800 | 5 | 4,000 | D |
| 26 Nov 2024 18:35 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 25 Nov 2024 | Sale | 1,600 | 5 | 8,000 | D |
| 26 Nov 2024 18:34 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 25 Nov 2024 | Sale | 240,000 | 4.9015 | 1,176,360 | D |
| 18 Nov 2024 16:20 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 18 Nov 2024 | Purchase | 20,000 | 4.44 | 88,800 | D |
| 13 Nov 2024 16:58 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 11 Nov 2024 | Sale | 2,400 | 5 | 12,000 | D |
| 13 Nov 2024 16:57 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 11 Nov 2024 | Sale | 2,400 | 5 | 12,000 | D |
| 07 Nov 2024 18:57 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 06 Nov 2024 | Purchase | 39,360 | 4.7988 | 188,881 | D |
| 07 Nov 2024 18:56 | VRNA | Verona Pharma plc | ACKERMANN CHRISTINA | Director | 06 Nov 2024 | Purchase | 41,880 | 4.737 | 198,386 | D |
| 05 Nov 2024 17:41 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 Nov 2024 | Sale | 46,888 | 4.3763 | 205,196 | D |
| 05 Nov 2024 17:41 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 04 Nov 2024 | Sale | 94,144 | 4.3918 | 413,462 | D |
| 05 Nov 2024 17:40 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Nov 2024 | Sale | 48,888 | 4.3761 | 213,939 | D |
| 05 Nov 2024 17:40 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Nov 2024 | Sale | 80,784 | 4.3876 | 354,448 | D |
| 25 Oct 2024 19:55 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 24 Oct 2024 | Sale | 141,360 | 4.3772 | 618,761 | D |
| 25 Oct 2024 19:55 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 25 Oct 2024 | Sale | 3,200 | 4.375 | 14,000 | D |
| 25 Oct 2024 19:54 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 23 Oct 2024 | Sale | 16 | 4.375 | 70 | D |
| 25 Oct 2024 19:54 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 24 Oct 2024 | Sale | 140,000 | 4.3773 | 612,822 | D |
| 25 Oct 2024 19:54 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 25 Oct 2024 | Sale | 4,800 | 4.3758 | 21,004 | D |
| 22 Oct 2024 20:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 18 Oct 2024 | Sale | 245,784 | 4.3809 | 1,076,755 | D |
| 22 Oct 2024 20:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 21 Oct 2024 | Sale | 110,456 | 4.3796 | 483,753 | D |
| 22 Oct 2024 20:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 22 Oct 2024 | Sale | 157,912 | 4.3868 | 692,728 | D |
| 22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 18 Oct 2024 | Sale | 249,728 | 4.3807 | 1,093,983 | D |
| 22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 21 Oct 2024 | Sale | 116,696 | 4.3796 | 511,082 | D |
| 22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 22 Oct 2024 | Sale | 159,344 | 4.3849 | 698,708 | D |
| 13 Sep 2024 16:15 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 11 Sep 2024 | Sale | 600,000 | 3.7572 | 2,254,320 | D |
| 13 Sep 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 11 Sep 2024 | Sale | 600,000 | 3.7568 | 2,254,080 | D |
| 14 Aug 2024 16:16 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 13 Aug 2024 | Sale | 390,184 | 3.201 | 1,248,979 | D |
| 14 Aug 2024 16:16 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 13 Aug 2024 | Sale | 8,216 | 3.25 | 26,702 | D |
| 14 Aug 2024 16:16 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 12 Aug 2024 | Sale | 1,600 | 3.13 | 5,008 | D |
| 14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 13 Aug 2024 | Sale | 3,736 | 3.25 | 12,142 | D |
| 14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 13 Aug 2024 | Sale | 394,664 | 3.2012 | 1,263,398 | D |
| 14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 12 Aug 2024 | Sale | 1,600 | 3.13 | 5,008 | D |
| 14 Aug 2024 16:15 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 12 Aug 2024 | Purchase | 36,000 | 2.87 | 103,320 | D |
| 03 May 2024 19:21 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 May 2024 | Sale | 36,248 | 1.9596 | 71,032 | D |
| 05 Feb 2024 18:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 05 Feb 2024 | Sale | 36,248 | 2.2209 | 80,503 | D |
| 22 Nov 2023 17:09 | VRNA | Verona Pharma plc | EDWARDS MARTIN | Director | 20 Nov 2023 | Purchase | 33,736 | 1.837 | 61,973 | D |
| 08 Nov 2023 16:15 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 06 Nov 2023 | Purchase | 160,000 | 1.9755 | 316,080 | D |
| 03 Nov 2023 20:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Nov 2023 | Sale | 58,752 | 1.92 | 112,804 | D |
| 07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 07 Aug 2023 | Sale | 1,600 | 2.4679 | 3,949 | D |
| 07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 04 Aug 2023 | Sale | 27,944 | 2.4992 | 69,838 | D |
| 07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Aug 2023 | Sale | 21,848 | 2.539 | 55,472 | D |
| 07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Aug 2023 | Sale | 28,752 | 2.55 | 73,318 | D |
| 07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 07 Aug 2023 | Sale | 8,616 | 2.4679 | 21,263 | D |
| 07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 04 Aug 2023 | Sale | 150,000 | 2.4992 | 374,880 | D |
| 07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 03 Aug 2023 | Sale | 117,272 | 2.539 | 297,754 | D |
| 07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 07 Aug 2023 | Sale | 8,616 | 2.4679 | 21,263 | D |
| 07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Aug 2023 | Sale | 150,000 | 2.4992 | 374,880 | D |
| 07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 03 Aug 2023 | Sale | 117,272 | 2.539 | 297,754 | D |
| 07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 07 Aug 2023 | Sale | 1,512 | 2.4679 | 3,731 | D |
| 07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 04 Aug 2023 | Sale | 26,352 | 2.4992 | 65,859 | D |
| 07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 03 Aug 2023 | Sale | 20,608 | 2.539 | 52,324 | D |
| 03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Aug 2023 | Sale | 105,944 | 2.679 | 283,824 | D |
| 03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 02 Aug 2023 | Sale | 73,704 | 2.593 | 191,114 | D |
| 03 Aug 2023 20:30 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 02 Aug 2023 | Sale | 12,944 | 2.593 | 33,564 | D |
| 03 Aug 2023 20:30 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 01 Aug 2023 | Sale | 18,608 | 2.679 | 49,851 | D |
| 03 Aug 2023 20:29 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 02 Aug 2023 | Sale | 73,704 | 2.593 | 191,114 | D |
| 03 Aug 2023 20:29 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 Aug 2023 | Sale | 105,944 | 2.679 | 283,824 | D |
| 03 Aug 2023 20:27 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 02 Aug 2023 | Sale | 13,728 | 2.593 | 35,597 | D |
| 03 Aug 2023 20:27 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 01 Aug 2023 | Sale | 19,736 | 2.679 | 52,873 | D |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 345,313 | 20 | 6,906,260 | I |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 14,400 | 21.96 | 316,224 | I |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 12 May 2023 | Sale | 43,200 | 21.64 | 934,848 | I |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 11 May 2023 | Sale | 80,000 | 22.26 | 1,780,800 | I |
| 15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 15 May 2023 | Sale | 345,313 | 20 | 6,906,260 | I |
| 15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 15 May 2023 | Sale | 14,400 | 21.96 | 316,224 | I |
| 15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 12 May 2023 | Sale | 43,200 | 21.64 | 934,848 | I |
| 15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 11 May 2023 | Sale | 80,000 | 22.26 | 1,780,800 | I |
| 03 May 2023 19:49 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 01 May 2023 | Sale | 80,376 | 2.5759 | 207,041 | D |
| 03 May 2023 19:49 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 May 2023 | Sale | 28,752 | 2.6517 | 76,242 | D |
| 03 May 2023 19:49 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 01 May 2023 | Sale | 77,424 | 2.5759 | 199,436 | D |
| 03 May 2023 19:48 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 May 2023 | Sale | 455,528 | 2.5759 | 1,173,395 | D |
| 03 May 2023 19:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 May 2023 | Sale | 455,536 | 2.5759 | 1,173,415 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)